Literature DB >> 15940740

Complementary medicine use by Australian women with gynaecological cancer.

Milica Markovic1, Lenore Manderson, Natalie Wray, Michael Quinn.   

Abstract

AIMS AND
OBJECTIVES: Social and cultural factors are identified that impact on complementary therapy use among Australia-born and immigrant women diagnosed with gynaecological cancer.
METHODS: A qualitative study design including in-depth interviews with women diagnosed with gynaecological cancer (N=53) and participant observation was conducted.
RESULTS: Approximately one-third of women utilized complementary and alternative medicine, with this being determined by current health concerns and health beliefs related to the efficacy of different modalities. Four types of complementary therapy users emerged: consequential, therapeutic, informed and exploratory.
CONCLUSION: There was a relatively low uptake of complementary treatments. Choice was influenced by women's socio-demographic background, clinical and personal history, lack of personal experiences of gynaecological cancer among study participants' kin and friends, and lack of popular alternative literature on such cancer.

Entities:  

Mesh:

Year:  2006        PMID: 15940740     DOI: 10.1002/pon.936

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  3 in total

1.  Quality of life, perceptions of health and illness, and complementary therapy use among people with type 2 diabetes and cardiovascular disease.

Authors:  Rachel Canaway; Lenore Manderson
Journal:  J Altern Complement Med       Date:  2013-06-21       Impact factor: 2.579

Review 2.  Decision-making about complementary and alternative medicine by cancer patients: integrative literature review.

Authors:  Laura Weeks; Lynda G Balneaves; Charlotte Paterson; Marja Verhoef
Journal:  Open Med       Date:  2014-04-15

Review 3.  Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use.

Authors:  Rebecca Reid; Amie Steel; Jon Wardle; Andrea Trubody; Jon Adams
Journal:  BMC Complement Altern Med       Date:  2016-06-11       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.